biperiden has been researched along with Basal Ganglia Diseases in 32 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Efficacy of ziprasidone (80-160 mg/d) and olanzapine 10-20 mg was measured using the Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impression (CGI) Scale, the Calgary Depression Scale for Schizophrenia (CDSS), and the Heinrich Quality of Life Scale (HQLS); tolerability assessments included laboratory assessments, body weight, and electroencephalogram." | 9.15 | Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. ( Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ, 2011) |
| " Efficacy of ziprasidone (80-160 mg/d) and olanzapine 10-20 mg was measured using the Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impression (CGI) Scale, the Calgary Depression Scale for Schizophrenia (CDSS), and the Heinrich Quality of Life Scale (HQLS); tolerability assessments included laboratory assessments, body weight, and electroencephalogram." | 5.15 | Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. ( Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ, 2011) |
| "A 52-year-old woman developed severe hyponatremia following treatment for hypertension with chlorthalidone." | 3.68 | Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. ( Goldhammer, Y; Sadeh, M, 1993) |
| "The pseudosclerotic type of Wilson's disease, also known as the Westphal-Strümpell form, is distinguished by positional tremor, ataxia and dysarthria as the main symptoms." | 1.30 | [Schizophrenia-like symptoms in the Westphal-Strümpell variation of Wilson disease]. ( Landgraf, F; Müller, J; Trabert, W, 1998) |
| "Two weeks after epidemic parotitis a 10-year old boy developed an acute extrapyramidal syndrome together with pyramidal tract signs but without impairment of consciousness." | 1.26 | [Encephalitis of the basel ganglia associated with mumps]. ( Heuser, L; Kellermann, K; Mertens, T, 1982) |
| "Biperiden hydrochloride has been used in the treatment of Parkinson's disease and related disorders within two drugs: --Akinophyl, --and Akineton which is chemically similar but has a slower effect." | 1.26 | [Treatment of the neuroleptic syndrome by biperiden hydrochloride under its delayed-action form. A 9-month study on 55 hospitalized patients]. ( Verdeau-Pailles, J, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (59.38) | 18.7374 |
| 1990's | 9 (28.13) | 18.2507 |
| 2000's | 1 (3.13) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niederhofer, H | 1 |
| Ota, T | 1 |
| Miura, I | 1 |
| Kanno-Nozaki, K | 1 |
| Hoshino, H | 1 |
| Horikoshi, S | 1 |
| Fujimori, H | 1 |
| Kanno, T | 1 |
| Mashiko, H | 1 |
| Yabe, H | 1 |
| Grootens, KP | 1 |
| van Veelen, NM | 1 |
| Peuskens, J | 1 |
| Sabbe, BG | 1 |
| Thys, E | 1 |
| Buitelaar, JK | 1 |
| Verkes, RJ | 1 |
| Kahn, RS | 1 |
| OPPENHEIMER, H | 1 |
| Baumann, CR | 1 |
| Jenni, R | 1 |
| Jung, HH | 1 |
| Fuhrmann, M | 1 |
| Hruby, K | 1 |
| Gössinger, H | 1 |
| Shroff, D | 1 |
| Gassner, B | 1 |
| Shen, WW | 1 |
| Wässer, S | 1 |
| Kellermann, K | 1 |
| Heuser, L | 1 |
| Mertens, T | 1 |
| Sadeh, M | 1 |
| Goldhammer, Y | 1 |
| Silver, H | 1 |
| Geraisy, N | 1 |
| Diltoer, MW | 1 |
| Rosseneu, S | 1 |
| Ramet, J | 1 |
| De Wolf, D | 1 |
| Spapen, HD | 1 |
| De Turck, BJ | 1 |
| Huyghens, LP | 1 |
| Higuchi, H | 1 |
| Shimizu, T | 1 |
| Hishikawa, Y | 1 |
| Meszaros, K | 1 |
| Lenzinger, E | 1 |
| Hornik, K | 1 |
| Schönbeck, G | 1 |
| Hatzinger, R | 1 |
| Langer, G | 1 |
| Sieghart, W | 1 |
| Aschauer, HN | 1 |
| Müller, J | 1 |
| Landgraf, F | 1 |
| Trabert, W | 1 |
| Dose, M | 1 |
| Hellweg, R | 1 |
| Yassouridis, A | 1 |
| Theison, M | 1 |
| Emrich, HM | 1 |
| Posada, IJ | 1 |
| López-Valdés, E | 1 |
| Vallejo, AR | 1 |
| Portera, A | 1 |
| Huffmann, G | 1 |
| Sinaniotis, CA | 1 |
| Spyrides, P | 1 |
| Vlachos, P | 1 |
| Papadatos, C | 1 |
| Jellinek, T | 1 |
| Verdeau-Pailles, J | 1 |
| Van Putten, T | 2 |
| Mutalipassi, LR | 2 |
| Staudt, F | 1 |
| Linder, M | 1 |
| Dilsaver, SC | 1 |
| Kline, NS | 1 |
| Mason, BT | 1 |
| Winick, L | 1 |
| Klett, CJ | 1 |
| Caffey, E | 1 |
| Simpson, GM | 1 |
| Beckles, D | 1 |
| Isalski, Z | 1 |
| Lee, JH | 1 |
| Malkin, MD | 1 |
| Ayd, FJ | 1 |
| Haase, HJ | 1 |
| Floru, L | 1 |
| Ulrich, F | 1 |
| Kammerer, T | 1 |
| Schweitzer-Bucher, E | 1 |
| Jamet, P | 1 |
| Royer, M | 1 |
| Delteil, P | 1 |
| Decreton, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Double-Blind, Randomized Trial Of Ziprasidone (80 - 160 Mg) Versus Olanzapine (10 - 20 Mg) In Patients With Recent-Onset Schizophrenia, Schizoaffective And Schizophreniform Disorder.[NCT00145444] | Phase 3 | 100 participants | Interventional | 2003-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for biperiden and Basal Ganglia Diseases
| Article | Year |
|---|---|
Side effects of depot fluphenazines.
Topics: Agranulocytosis; Barbiturates; Basal Ganglia Diseases; Benztropine; Biperiden; Delayed-Action Prepar | 1974 |
10 trials available for biperiden and Basal Ganglia Diseases
| Article | Year |
|---|---|
Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment: A Randomized, Open-Label Study.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; | 2015 |
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.
Topics: Adult; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Basal Ganglia Diseas | 2011 |
No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
Topics: Adult; Amantadine; Basal Ganglia Diseases; Biperiden; Chronic Disease; Cross-Over Studies; Dopamine | 1995 |
Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
Topics: Adult; Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Chroni | 1997 |
Combined treatment of schizophrenic psychoses with haloperidol and valproate.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Brief Psychiatric Rating Scale; Chlo | 1998 |
Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Biperid | 1974 |
Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Topics: 1-Propanol; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Benztropine; Biperiden; Chronic Dis | 1972 |
Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Chronic Disease; Clinical Trials as | 1972 |
Phenothiazine-induced decompensation.
Topics: Adult; Affective Symptoms; Basal Ganglia Diseases; Biperiden; Clinical Trials as Topic; Dose-Respons | 1974 |
[Clinical-neuroleptic investigation of N-((1-ethyl-pyrrolidine-2-yl)-methyl)-2-methoxy-5-sulfamyl-benzamide-neuroleptic sulpiride (Dogmatil) in acutly ill schizophrenics].
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Biperiden; Blood Pressure; Clinical Trials as Topic | 1974 |
21 other studies available for biperiden and Basal Ganglia Diseases
| Article | Year |
|---|---|
Tizanidine is not effective treating EPMS.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Biperiden; Cholinergic Antagonists; Clonidine; Clopenthix | 2018 |
[On the treatment of drug-induced extrapyramidal syndromes with akineton].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Disease; Extrapyramidal Tracts; Parasympath | 1961 |
Severe extrapyramidal syndrome after exposition to isoamyl acetate vapour.
Topics: Acetylcholine; Adult; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Biperiden; Brain; G | 2008 |
[Clinical aspects and therapy of acute poisoning by the drug combination melitracen-flupenthixol (Deanxit)].
Topics: Adolescent; Adult; Anthracenes; Basal Ganglia Diseases; Biperiden; Cardiac Complexes, Premature; Chi | 1983 |
Extrapyramidal symptoms associated with alcohol withdrawal.
Topics: Aged; Alcoholism; Basal Ganglia Diseases; Biperiden; Dystonia; Female; Humans; Male; Middle Aged; Pa | 1984 |
[Making a diagnosis. Side effects of metoclopramide].
Topics: Attention Deficit Disorder with Hyperactivity; Basal Ganglia Diseases; Biperiden; Child; Humans; Mal | 1982 |
[Encephalitis of the basel ganglia associated with mumps].
Topics: Basal Ganglia Diseases; Biperiden; Child; Electroencephalography; Encephalitis; Humans; Lymphocytosi | 1982 |
Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis.
Topics: Basal Ganglia Diseases; Biperiden; Carbidopa; Chlorthalidone; Coma; Drug Therapy, Combination; Femal | 1993 |
Anticholinergic treatment for choreoathetosis in a child after induction with propofol.
Topics: Anesthetics, Intravenous; Athetosis; Basal Ganglia Diseases; Biperiden; Child; Cholinergic Antagonis | 1996 |
Recurrent paroxysmal episodes characterized by perceptual alteration in three schizophrenic patients on neuroleptic medication.
Topics: Adult; Affect; Antipsychotic Agents; Anxiety; Auditory Perception; Basal Ganglia Diseases; Biperiden | 1997 |
[Schizophrenia-like symptoms in the Westphal-Strümpell variation of Wilson disease].
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Biperiden | 1998 |
Extrapyramidal side effects and serotonin syndrome with fluoxetine and biperiden.
Topics: Aged; Basal Ganglia Diseases; Biperiden; Depression; Fluoxetine; Humans; Male; Parasympatholytics; S | 1998 |
[Akineton delir and other emergencies caused by psychopharmaca].
Topics: Adult; Age Factors; Alcohol Withdrawal Delirium; Basal Ganglia Diseases; Biperiden; Diagnosis, Diffe | 1978 |
Acute haloperidol poisoning in children.
Topics: Acute Disease; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Child; Child, Preschool; Dys | 1978 |
Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication.
Topics: Adolescent; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Emotions; Euphoria; Fema | 1977 |
[Treatment of the neuroleptic syndrome by biperiden hydrochloride under its delayed-action form. A 9-month study on 55 hospitalized patients].
Topics: Adult; Aged; Basal Ganglia Diseases; Biperiden; Delayed-Action Preparations; Drug Tolerance; Female; | 1976 |
Fluphenazine enanthate induced decompensations.
Topics: Adult; Basal Ganglia Diseases; Biperiden; Female; Fluphenazine; Humans; Male; Schizophrenia | 1975 |
[Extrapyramidal movement disorders after "Isostar Cocktail"].
Topics: Adolescent; Basal Ganglia Diseases; Beverages; Biperiden; Dyskinesia, Drug-Induced; Food Contaminati | 1992 |
Effects of neuroleptics on body temperature.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Body Temperature; Dibenzothiepins; | 1988 |
[Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
Topics: 1-Propanol; Adolescent; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Catatonia; D | 1972 |
[Clinical trial of delayed-action Akinophyl (Akineton)].
Topics: 1-Propanol; Adjustment Disorders; Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Anxiety | 1972 |